Hypothesis

Age‑associated gut dysbiosis elevates circulating phenylacetic acid and reduces short‑chain fatty acids, which together impair vagal afferent signaling and promote hippocampal microglial senescence, driving memory loss.

Mechanistic Rationale

Phenylacetic acid, produced by excess phenylalanine‑catabolizing microbes, can diffuse into the bloodstream and reach the nodose ganglion where vagal afferent soma reside. We propose that phenylacetic acid acylates lysine residues on transient receptor potential vanilloid 1 (TRPV1) and piezo2 channels, decreasing their sensitivity to mechanical stretch and reducing afferent firing. Concurrently, depleted butyrate and propionate lower histone deacetylase (HDAC) activity in vagal neurons, leading to hyperacetylation of pro‑inflammatory gene promoters (e.g., Il6, Tnf) and a shift toward a neuroimmune phenotype that further dampens signal transmission.

In the hippocampus, reduced vagal tone lessens cholinergic anti‑inflammatory signaling, allowing microglial activation. Phenylacetic acid also enters the brain via compromised endothelial tight junctions (itself exacerbated by phenylacetic acid‑induced endothelial senescence) and directly acetylates microglial NF‑κB p65, amplifying cytokine production. Meanwhile, low SCFA levels diminish microglial PPARγ activation, impairing phagoptotic clearance of synaptic debris. The combined effect is exaggerated synaptic pruning and CNTF overexpression, which correlates with memory deficits.

Testable Predictions

1. Plasma phenylacetic acid concentration will inversely correlate with vagal afferent firing rate measured by in vivo electrophysiology in aged mice.
2. Fecal butyrate levels will positively correlate with hippocampal microglial PPARγ expression and inversely with IL‑1β levels.
3. Pharmacological scavenging of phenylacetic acid (using phenylacetyl‑glutamine) or oral butyrate supplementation will restore vagal firing, reduce hippocampal microglial activation, and improve performance on the Morris water maze.
4. Genetic knockdown of TRPV1 acetylation sites in vagal neurons will phenylacetic acid‑resistant, preserving afferent signaling despite high phenylacetic acid levels.

Experimental Design

• Cohorts: Young (3 mo), aged (20 mo) mice, and aged mice receiving phenylacetic acid scavenger, butyrate, or vehicle.
• Measurements:
  • Plasma phenylacetic acid (LC‑MS), fecal SCFA (GC‑MS).
  • Vagal afferent firing (ex vivo vagus nerve preparation, suction electrode).
  • Hippocampal microglial morphology (Iba1 staining), PPARγ and acetylated NF‑κB (immunofluorescence).
  • Synaptic density (synaptophysin puncta), CNTF levels (ELISA).
  • Behavioral: Morris water maze escape latency, novel object recognition.
• Controls: Sham‑treated aged mice, antibiotic‑treated microbiota‑depleted mice to confirm microbiome dependence.
• Statistical plan: Pearson correlation for metabolite‑physiology links; two‑way ANOVA with post‑hoc Tukey for treatment effects; power analysis targeting n = 10 per group to detect 20 % change with α = 0.05, power = 0.8.

If predictions hold, the data will support a dual‑hit model where microbial metabolites directly blunt vagal sensitization and concomitantly disinhibit hippocampal microglial senescence, offering precise intervention points beyond broad microbiome modulation.